17 juin: L'Agence Spatiale Européenne a retenu Atos Origin comme « Qualifi..
17 juin: RUBIS : contrat de liquidité
17/06/2010 15:26:00

Patterson Medical Acquires Rehabilitation Operating Units of DCC plc

Related content

Patterson Medical, the rehabilitation supply and equipment unit of

Patterson Companies, Inc. (Nasdaq: PDCO) today announced the acquisition

of the rehabilitation businesses of DCC Healthcare, a division of DCC

plc (Irish Stock Exchange: DCC.I), a business support services group

headquartered in Dublin, Ireland. Terms of the all-cash transaction were

not disclosed.

The acquired DCC businesses—Days Healthcare, Physiomed and Ausmedic—rank

among the leaders in their respective overseas markets, providing

assistive living products and rehabilitation equipment and supplies to

hospitals, physical and occupational therapists, long-term care

facilities, dealers and consumers in the U.K., continental Europe,

Australia, New Zealand and other international markets.

Days, Physiomed and Ausmedic posted combined sales of approximately $70

million for the fiscal year ended March 31, 2010, while Patterson

Medical reported sales of $426 million for the year ended April 24,

2010. The acquisition is expected to have a neutral impact on

Patterson’s consolidated earnings in fiscal 2011 and then be accretive

starting in its second year as part of the company.

David P. Sproat, president of Patterson Medical, commented: “This

strategic acquisition significantly strengthens the market presence and

geographic reach of our Homecraft Rolyan unit in the U.K. In addition to

expanding Homecraft’s position in the U.K.’s physical and occupational

therapy markets, this transaction brings a stable of trusted and

established brand names that encompass an extensive range of

rehabilitation and assistive living products. This acquisition also

increases HomeCraft’s international coverage, including strong positions

in the Australia and New Zealand rehabilitation markets, where we

previously had a limited presence. Also part of this transaction is a

sourcing team in China.”

He added: “Consolidating DCC’s rehabilitation businesses into Homecraft

Rolyan will enable us to more fully leverage our existing U.K. capacity,

capture significant synergies among our operating units and provide

greater opportunities for the employees of Days Healthcare, Physiomed

and Ausmedic. In all, this acquisition will strengthen our presence in

the large and growing global rehabilitation market, making us believe

this transaction should spur Patterson Medical’s profitable growth.”

About Patterson Companies, Inc.

Patterson Companies, Inc. is a value-added distributor serving the

dental, companion-pet veterinarian and rehabilitation supply markets.

Dental Market

As Patterson’s largest business, Patterson Dental provides a virtually

complete range of consumable dental products, equipment and software,

turnkey digital solutions and value-added services to dentists and

dental laboratories throughout North America.

Veterinary Market

Webster Veterinary is a distributor of consumable veterinary supplies,

equipment and software, diagnostic products, vaccines and

pharmaceuticals to companion-pet veterinary clinics.

Rehabilitation Market

Patterson Medical is a distributor of rehabilitation supplies and

non-wheelchair assistive patient products to the physical and

occupational therapy markets. The unit’s global customer base includes

hospitals, long-term care facilities, clinics and dealers.

This release contains forward-looking statements as defined in the

Private Securities Litigation Reform Act of 1995. Forward-looking

statements are information of a non-historical nature and are subject to

risks and uncertainties that are beyond the Company’s ability to

control. The Company cautions shareholders and prospective investors

that the following factors, among others, may cause actual results to

differ materially from those indicated by the forward-looking

statements: competition within the dental, veterinary, and

rehabilitative and assistive living supply industries; changes in the

economics of dentistry, including reduced growth in expenditures by

private dental insurance plans, the effects of economic conditions and

the effects of healthcare reform, which may affect future per capita

expenditures for dental services and the ability and willingness of

dentists to invest in high-technology products; the effects of

healthcare related legislation and regulation which may affect

expenditures or reimbursements for rehabilitative and assistive

products; changes in the economics of the veterinary supply market,

including reduced growth in per capita expenditures for veterinary

services and reduced growth in the number of households owning pets; the

ability of the Company to maintain satisfactory relationships with its

sales force; unexpected loss of key senior management personnel;

unforeseen operating risks; risks associated with the dependence on

manufacturers of the Company’s products; and the ability of the Company

to successfully integrate the recent acquisitions into its existing

business. Forward-looking statements are qualified in their entirety by

the cautionary language set forth in the Company's filings with the

Securities and Exchange Commission.

Patterson Companies, Inc.

R. Stephen Armstrong, 651-686-1600


Vice President & CFO


Equity Market Partners


G. Cinquina, 904-415-1415

17 juin: L'Agence Spatiale Européenne a retenu Atos Origin comme « Qualifi..
17 juin: RUBIS : contrat de liquidité

Envoyer un commentaire

Related debate

  • 1 semaine
  • 1 mois
  • 1 an
Ingen indlæg


Actualité la plus lue

  • 24 heures
  • 48 heures
  • 1 semaine
Sanofi : Le New England Journal of Medicine publie les résultats positifs de deux essais cliniques de phase III montrant que Dupixent® (dupilumab) améliore l'asthme modéré à sévère
Atos et le CEA lancent une chaire industrielle sur l'informatique quantique, avec le soutien de l'ANR
CRCAM Brie Picardie - déclaration hebdomadaire - Rachats réalisés dans les conditions de l'article 5 du Règlement MAR
Neoditel annonce un chiffre d'affaires proche de 2,2 millions d'euros pour l'exercice 2017

Related stock quotes

Patterson Companies Inc 21,92 -0,8% Cours de bourse en baisse

Buy and sell signals

  • Tendance
  • Moneymachine

Droit d'auteur Euroinvestor A/S 2018   Mentions légales et conditions d'utilisation
Information sur les cours fournies par Morningstar.
Les données sont différées de 15 à 20 minutes selon les accords avec les différentes bourses internationales.
mardi 22 mai 2018 17:41:34
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180515.2 - EUROWEB7 - 2018-05-22 17:41:34 - 2018-05-22 17:41:34 - 4 - Website: OKAY